Uterine Fibroid Embolization Product Overview

Since 1999, BioSphere Medical's primary mission has been to be a global leader in embolotherapy. The Company is pioneering the use of patented bioengineered microspheres and Uterine Fibroid Embolization as a new class of embolics for the treatment of tumors and vascular malformations by occluding their blood supply. We are driving demand for our proprietary microsphere technology as we penetrate additional key markets and launch additional products to support the ever-changing market demands.

Our first product, Embosphere® Microspheres, has been on the market in the U.S. since April, 2000. Our new, visible microsphere product, EmboGold™ Microspheres, was launched in the U.S. in September, 2001. We have completed Phase I and Phase II for FDA clearance to add the indication of treating uterine fibroids. The Company expects to have this approval by the end of 2002. In March of 2002, we received both CE and Canadian approvals to sell EmboGold Microspheres in Europe and Canada.

Controlled, Targeted Uterine Fibroid Embolization

BioSphere Medical's microspheres are precisely calibrated, spherical, hydrophilic, micro-porous beads made of an acrylic co-polymer (trisacryl) which is then cross-linked with gelatin. This proprietary and patented design allows a more complete and targeted occlusion of the blood vessels feeding a hypervascularized tumor or arteriovenous malformation. Furthermore, the hydrophilic surface and spherical shape prevent aggregation within the catheter lumen and in the vasculature, promoting ease and accuracy of delivery. Finally, the elastic properties of the microspheres also allow the temporary deformation of the sphere, which facilitates the passage through small delivery systems. Uterine Fibroid Embolization, the future is now.

Click images for a larger view
Embospheres: Flexible spheres Non Aggregating Uniform occlusion Predictable penetration	PVA: Irregular shape Clumping Non-uniform occlusion More proximal occlusion

Click images for a larger view
Compressible and Hydrophilic: Elastic shape and hydrophilic surface prevent aggregation within the catheter, simplifying handling and promoting accurate delivery to the target vessel.

Preparation and Administration for Uterine Fibroid Embolization
One of the major benefits to Embosphere® Microspheres and EmboGold™ Microspheres is the packaging design which allows ease of use. In order to leverage the benefits derived from the packaging, it is important to follow some very simple preparation and administration steps. Please contact your local sales representative to schedule an in-service with one of our clinical specialists.

For details on how to Prepare and Administer EmboGold Microspheres,
please click here

Click here for a Microcatheter Compatibility Chart

Site Map

Contact BioSphere Medical · Privacy Statement

Patients
    Patients Overview
    Journal Articles
    Company Literature
    Other Resources